ABIVAX Société Anonyme (EPA:ABVX)
113.40
-0.10 (-0.09%)
May 29, 2026, 5:36 PM CET
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
69
Change
n/a
Growth
n/a
Revenue / Employee
€61,500
Profits / Employee
€4,152,500
Market Cap
9.04B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 69 | 0 | - | 69 | 0 |
| Sep 30, 2025 | 67 | 5 | 8.06% | 67 | 0 |
| Jun 30, 2025 | 69 | 7 | 11.29% | 69 | 0 |
| Mar 31, 2025 | 69 | 8 | 13.11% | 69 | 0 |
| Dec 31, 2024 | 69 | 8 | 13.11% | 69 | 0 |
| Jun 30, 2024 | 62 | - | - | 62 | 0 |
| Dec 31, 2023 | 61 | 37 | 154.17% | 61 | 0 |
| Dec 31, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | 24 | -3 | -11.11% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cellectis | 229 |
| Genfit | 188 |
| Innate Pharma | 164 |
| DBV Technologies | 161 |
| MedinCell | 145 |
| Transgene | 145 |
| Nanobiotix | 100 |
ABIVAX Société Anonyme News
- 9 days ago - Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis - GlobeNewsWire
- 9 days ago - ABIVAX Société Anonyme Earnings release: Q1 2026 - Filings
- 9 days ago - ABIVAX Société Anonyme Earnings release: Q1 2026 - Filings
- 19 days ago - Abivax put volume heavy and directionally bearish - TheFly
- 26 days ago - Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares - GlobeNewsWire
- 5 weeks ago - Abivax to Present Data on Obefazimod at Digestive Disease Week® - GlobeNewsWire
- 5 weeks ago - Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents - GlobeNewsWire
- 7 weeks ago - Abivax price target raised to EUR 120 from EUR 88 at Oddo BHF - TheFly